Women who receive a type of partial-breast radiation called brachytherapy may have higher rates of breast cancer recurrence and side effects.
Mammograms starting at age 40 may have an acceptable balance of risks and benefits for women with extremely dense breasts or a family history of the disease, two studies suggested.
Although breast cancer-related fatigue is common, it generally runs a self-limiting course and does not persist as long as people had thought; especially in cases of early-stage breast cancer, researchers reported in the Journal of Clinical Oncology...
The FDA voted unanimously to recommend the expanded use of automated breast ultrasound (ABUS) as a screening tool for women with dense breast tissue who have not had previous breast biopsies or surgeries.
After careful consideration by experienced oncologists, ASCO highlights five categories of tests, procedures and/or treatments whose common use and clinical value are not supported by available evidence.
SAN FRANCISCO – The EMILIA study showed trastuzumab emtansine significantly extended the time people with HER2-Positive metastatic breast cancer lived without their disease getting worse.
SAN FRANCISCO -- Five-year risk of lymphedema can be predicted with at least 70% accuracy using a free online statistical tool, researchers found.
A recent study shows personalized medicine may be more complex than originally thought. But Y-ME peer counselor Jane Perlmutter, Ph.D, cautions current patients about altering their own treatment regimen.
An inherited mutation in the Abraxas gene, which encodes a protein that interacts with BRCA1 and other DNA-repair proteins, is associated with an increased risk of breast cancer in some families, new study results show.
Many of us have blamed our addled moments on a poorly-understood phenomenon referred to as "chemobrain," but until now, it's never been clear that the condition actually exists. A recent report in the Journal of Clinical Oncology sheds some light...